Steven Brandwein Net Worth & Insider Trades
Steven Brandwein - Interim Chief Financ. Officer, Arcadia Biosciences, Inc
What is Steven Brandwein's Net Worth?
The current estimated net worth of Arcadia Biosciences, Inc's Interim Chief Financ. Officer, Steven Brandwein, is estimated to be about $62.95K . Steven Brandwein owns about 40,715 units of Arcadia Biosciences, Inc common stock. In the last 2 months at Arcadia Biosciences, Inc, Steven Brandwein has sold an estimated value of $24.81K worth.
What is Steven Brandwein's Past Insider Trading?
Steven Brandwein's largest sale order was 8,280 units , worth over $20.65K on June 15, 2016. In total, Steven Brandwein has made about 2 transactions over 2 months of their time at Arcadia Biosciences, Inc. Steven Brandwein usually trades in April and June, with the busiest year in 2016.
Steven Brandwein
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Steven Brandwein's' Mailing Address?
- Mailing address is Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618 CA
Arcadia Biosciences, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Matthew T. Plavan | 2020 | $370,000 | - | - | $325,642 | $98,506 | - | $794,148 |
| Matthew T. Plavan | 2019 | $321,538 | - | - | $105,040 | $154,500 | - | $581,078 |
| Pamela Haley | 2020 | $240,000 | - | - | $171,391 | $31,800 | - | $443,191 |
| Pamela Haley | 2019 | $212,671 | - | - | $16,564 | $55,800 | - | $285,035 |
| Randall Shultz | 2020 | $244,923 | $12,500 | - | $158,157 | $15,900 | - | $431,480 |
| Randall Shultz | 2019 | $160,096 | $12,500 | - | $85,500 | $39,200 | $42,268 | $339,564 |
| Sarah Reiter | 2020 | $210,972 | - | - | $214,241 | - | $101,942 | $527,155 |
| Sarah Reiter | 2019 | $268,840 | $12,500 | - | $94,152 | $80,900 | - | $456,392 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459021019590/rkda-def14a_20210602.htm
What are Arcadia Biosciences, Inc's Past Insider Trades?
Arcadia Biosciences, Inc's most recent insider trade came on February 2, 2023 by Thomas Schaefer who bought 700 units worth $161 . In the last 8 years, insiders at Arcadia Biosciences, Inc have sold an estimated value of $1.76M and bought an estimated value of $23.25M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Eric Rey, Director, Kevin Comcowich, Director, and Matthew Plavan, Chief Executive Officer .
Arcadia Biosciences, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||